(Philadelphia, PA - April 7, 2005) In an era of increased scrutiny on the prescribing of opiates in the United States, the withdrawal of Vioxx - and today Bextra - from the US market, and the growing awareness of the debilitating effects of widespread chronic pain around the world, The Scientist is proud to present a new supplement, Pain, an in-depth look at what's next for pain research and treatment.
According to the National Institutes of Health, 100 million people in the United States suffer from chronic pain, costing about $79 billion a year in care and lost work time. Biomedical research is inching ever closer to an understanding of the maddeningly subjective but nearly universal experience. Now, The Scientist offers its unique brand of coverage to call to attention to what has been done and what remains unanswered halfway through the congressionally mandated decade of pain.
"With the Vioxx ...
